Content Please enter your email address and password:

Forgotten your password? Click here.

We are the Pharmacy Law & Ethics Association

Latest News

Results page: [Prev] 1 2 3 ... 30 31 32 33 34 35 36 ... 38 39 40 [Next]

PLEA joins the world of social media

Posted: Tuesday, September 3rd, 2013

PLEA has joined the worlds of Twitter and Facebook to help us spread our accessibility and make more people aware of our existence. For now both resources will be used to highlight PLEA news items as on the website, but who knows where we will go!

To follow us on Twitter please search for @PLEA_UK

To view our Facebook page please go to and "like" our page

Please note that access to both these pages requires a personal account with the respective provider to access the information feeds. Our Facebook page is just that, a page to provide information. It has not been set up to allow public discussion. We would be delighted if you would use our Forum section on the PLEA website (accessible after member login) for such discussion.

Ban lifted on HIV testing kits

Posted: Wednesday, August 28th, 2013

The Health and Social care Act 2012 (Part 2 s.59) repealed the 1987 AIDS (Control) Act and its regulations which banned the marketing of diagnostic tests for human immunodeficiency disease (HIV). The Department of Health for England has announced that it intends to encourage the provision of training for suppliers of these kits and for those who buy them and will lift some of the restrictions on health workers with HIV from undertaking certain medical procedures.

Prescribing by Physios and Podiatrists

Posted: Wednesday, August 28th, 2013

The Human Medicines (Amendment) Regulations 2013 SI No. 1855 largely came into force on 20th August 2013. They enact independent prescribing by appropriately trained physiotherapists and podiatrists and implement the falisfied medicines directive.

Guidance on Patient Group Directions

Posted: Wednesday, August 28th, 2013

Following the changes to NHS England structures, the PGD website and NICE guidelines have been updated.

Hospital Pharmacy Europe conference

Posted: Tuesday, August 27th, 2013

PLEA members in or associated with the hospital service may be interested in the Hospital Pharmacy Europe Conference which will be at the Hilton Birmingham Metropole on October 29th 2013. (Quote)The day will address two of the key issues facing Europe’s hospital pharmacy community: Safety and Affordability, equipping participants with the knowledge and confidence to deliver and maintain the highest standards of patient and healthcare worker safety whilst staying within budget and in accordance with European legislation

Regulations on falsified medicines now in force

Posted: Friday, August 23rd, 2013

The Human Medicines (Amendment) Regulations 2013 SI No. 1855 which implement European requirements on falsified medicines came into force on 20th August 2013. More information is available on a dedicated section of the MHRA website.

Availability of diclofenac as a P medicine

Posted: Monday, August 19th, 2013

The MHRA is consulting on the continued availability of diclofenac as a Pharmacy medicine and the safety recommendations from the Commission on Human Medicines. Consultation closes on 28th October 2013.

Tramadol to become Sch. 3 CD

Posted: Wednesday, July 24th, 2013

The Home Office has issued a consultation on the placing of tramadol in schedule 3 to the Misuse of Drugs Act 1971. The consultation also questions the continuation of the exemption from prescription requirements for temazepam. Consultation closes on 11th October 2013

Proposal to end sell through of u/l herbals

Posted: Sunday, July 14th, 2013

The MHRA is undertaking a public consultation to end the "sell through" of unlicensed herbal medicines on the market at April 2011. It propses 31st December as the cut off date. Consultation closes on 6th September 2013.

EU Court overrules EMA licensing decision

Posted: Friday, July 12th, 2013

According to an article in PharmaTimes, the European Court has over-ruled a decision by the European Court/European Medicines Agency (EMA) not to license an "orphan" drug - Orphacol (cholic acid) - for rare liver diseases. One of the lawyers involved said "This judgement is the first to provide guidance on what type of use qualifies under the "well established use" procedure for obtaining an MA, and the first to interpret the "exceptional circumstances" provision.

Results page: [Prev] 1 2 3 ... 30 31 32 33 34 35 36 ... 38 39 40 [Next]

These news items are not exhaustive but are selected according to their relevance to pharmacy practice, NHS community pharmacy contracts and the regulation of the pharmacy profession. If you wish to add any items that you think we have missed, contact our news editor.